Sun Pharma slumps in early trade

Reuters | | Updated on: Dec 06, 2021

Shares in Sun Pharmaceutical Industries slumped as much as 16 per cent, heading towards their biggest daily fall ever, after the drugmaker on Monday said it sees 2016 sales flat at best.

Analysts say results warning can cut FY16 consensus earnings estimates by 8-10 per cent as company struggles to fix manufacturing problems at Ranbaxy Laboratories, which it bought last year.

At 9.30 am, the Sun Pharma pared its losses a bit, but still trading down 13.5 per cent or Rs 128 at Rs 820 on the NSE.

Published on July 21, 2015
This article is closed for comments.
Please Email the Editor

You May Also Like

Recommended for you